Cargando…
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance
Cancer is the second leading cause of death worldwide. The survival of cancer patients depends on the efficacy of therapies and the development of resistance. There are many mechanisms involved in the acquisition of drug resistance by cancer cells, including the acquisition of stem-like features. Ca...
Autores principales: | Ciccone, Valerio, Morbidelli, Lucia, Ziche, Marina, Donnini, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086516/ https://www.ncbi.nlm.nih.gov/pubmed/35582039 http://dx.doi.org/10.20517/cdr.2019.70 |
Ejemplares similares
-
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
por: Ciccone, Valerio, et al.
Publicado: (2018) -
Correction to: Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells
por: Ciccone, Valerio, et al.
Publicado: (2019) -
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL-8/Notch signaling cascade
por: Ciccone, Valerio, et al.
Publicado: (2022) -
ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output
por: Terzuoli, Erika, et al.
Publicado: (2019) -
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents
por: Morbidelli, Lucia, et al.
Publicado: (2016)